Under review
Pharma-Deko has not reached a conclusive verdict. Its business activity needs evidence-backed review before Qistal will publish a ruling either way.
NGX: PHARMDEKO · Healthcare · Screened 30 Aug 2026
Not yet determined. Pharma-Deko (PHARMDEKO) does not currently carry a conclusive Qistal verdict.
Qistal re-screens every NGX ticker when new audited or interim accounts are filed. This page always shows the date of the most recent screen.
Yes. Compliance drifts as a company borrows, raises cash, or changes its business mix, so a verdict describes a moment rather than a permanent status.